Local Injection and Systemic Therapy in the Treatment of NSCLC.

NCT06618391 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

84

Enrollment

OTHER_GOV

Sponsor class

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG: Envafolimab
DRUG: Recombinant human endostatin
DRUG: recombinant human adenovirus type 5

Sponsor

Henan Cancer Hospital